Clinical trials - Johnson & Johnson

Clinical trials  Johnson & Johnson

Avistone Announces Preclinical Results for ANS03, a Novel Type II ROS1/NTRK Inhibitor in Overcomi...

Avistone Announces Preclinical Results for ANS03, a Novel Type II ROS1/NTRK Inhibitor in Overcoming Clinically Relevant ROS1/NTRK Resistance Mutations at AACR Annual Meeting 2025  BioSpace

Akiram advances trial of targeted radiotherapy for solid tumours - PharmaTimes

Akiram advances trial of targeted radiotherapy for solid tumours  PharmaTimes

Utility of Digital Twin AI-Generated Models to Improve Patient Selection in Alzheimer Trials - Ne...

Utility of Digital Twin AI-Generated Models to Improve Patient Selection in Alzheimer Trials  NeurologyLive

The FDA Has Cleared the First Clinical Trial Application for a Prime Editor - CRISPR Medicine News

The FDA Has Cleared the First Clinical Trial Application for a Prime Editor  CRISPR Medicine News

Compass plans IPO to take 'magic mushroom' drug to phase 3 - Fierce Biotech

Compass plans IPO to take 'magic mushroom' drug to phase 3  Fierce Biotech

“Solidarity” clinical trial for COVID-19 treatments - World Health Organization (WHO)

“Solidarity” clinical trial for COVID-19 treatments  World Health Organization (WHO)

Biological, clinical, and ethical advances of placebo effects - The Lancet

Biological, clinical, and ethical advances of placebo effects  The Lancet

米バクサート、経口型コロナワクチンの初期治験開始 - Reuters

米バクサート、経口型コロナワクチンの初期治験開始  Reuters